首页> 外文期刊>European review for medical and pharmacological sciences. >Correlation between long strand non-coding RNA GASS expression and prognosis of cervical cancer patients
【24h】

Correlation between long strand non-coding RNA GASS expression and prognosis of cervical cancer patients

机译:长链非编码RNA GASS表达与宫颈癌患者预后的相关性

获取原文
           

摘要

OBJECTIVE: Cervical cancer is the second popular female specific malignant tumors. Long-strand non-coding RNA (lncRNA) GAS5 (Growth Arrest Specific 5) participates in pathological processes of various malignant tumors. This study aimed at investigating the correlation between lncRNA GAS5 expression and prognosis of cervical cancer patients. PATIENTS AND METHODS: Cancer tissues were collected from 48 cervical cancer patients. GAS5 expression in cervical cancer cells was determined by qRT-PCR and in situ hybridization (ISH). The correlation between GAS5 expression and pathological parameters of patients was analyzed. Cervical cancer cell line HeLa was used as the in vitro model, RNA interference approach was adopted to suppress lnc-RNA GAS5 expression. MTT assay was employed to analyze cell proliferation potency. Transwell assay was conducted to analyze the cell migration potency, and tumor cell invasion was measured. RESULTS: qRT-PCR and ISH results showed that GAS5 expression in cervical cancer tissues was significantly inhibited compared to that in adjacent tissues ( p <0.05). GAS5 expression was correlated with FIGO stage and metastatic tumor parameters of cervical cancer patients ( p <0.01). RNA interference data showed that the down-regulation of GAS5 significantly enhanced cell proliferation and invasion potency ( p <0.05). CONCLUSIONS: GAS5 is down-regulated in cervical cancer cells, and this is probably related to patient clinical stage and tumor invasion or metastasis. The regulatory role of GAS5 on cell proliferation provides the academic basis for the future therapy of cervical cancer.
机译:目的:宫颈癌是第二种流行的女性特异性恶性肿瘤。长链非编码RNA(lncRNA)GAS5(生长抑制特异性5)参与各种恶性肿瘤的病理过程。这项研究旨在调查lncRNA GAS5表达与宫颈癌患者预后之间的相关性。患者与方法:从48例宫颈癌患者中收集癌组织。通过qRT-PCR和原位杂交(ISH)确定子宫颈癌细胞中GAS5的表达。分析了GAS5表达与患者病理参数之间的相关性。以宫颈癌HeLa细胞为体外模型,采用RNA干扰方法抑制lnc-RNA GAS5表达。使用MTT测定法分析细胞增殖能力。进行Transwell分析以分析细胞迁移能力,并测量肿瘤细胞侵袭。结果:qRT-PCR和ISH结果表明,宫颈癌组织中GAS5的表达明显高于癌旁组织(p <0.05)。 GAS5表达与宫颈癌患者的FIGO分期和转移性肿瘤参数相关(p <0.01)。 RNA干扰数据显示,GAS5的下调显着增强了细胞增殖和侵袭力(p <0.05)。结论:GAS5在宫颈癌细胞中被下调,这可能与患者的临床分期以及肿瘤的侵袭或转移有关。 GAS5对细胞增殖的调控作用为宫颈癌的未来治疗提供了学术基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号